Concepedia

Favipiravir for symptomatic COVID-19: A nationwide observational cohort study

Yohei Doi, Takuma Ishihara, Sumi Banno, Masahiko Ando, Masashi Kondo

Journal of Infection and Chemotherapy · 2022 · 23 citations · 8 references

DOIFull text

Open access

Concepts

References

8

Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs

Sangeun Jeon, Meehyun Ko, Jihye Lee et al. · Antimicrobial Agents and Chemotherapy · 2020 · 714 citations · Full text

, , +15

Rapid incorporation of Favipiravir by the fast and permissive viral RNA polymerase complex results in SARS-CoV-2 lethal mutagenesis

Ashleigh Shannon, Barbara Selisko, Thi-Tuyet-Nhung Le et al. · Nature Communications · 2020 · 305 citations · Full text

, , +17

Favipiravir at high doses has potent antiviral activity in SARS-CoV-2−infected hamsters, whereas hydroxychloroquine lacks activity

Suzanne J. F. Kaptein, Sofie Jacobs, Lana Langendries et al. · Proceedings of the National Academy of Sciences · 2020 · 287 citations · Full text

, , +17

A Prospective, Randomized, Open-Label Trial of Early versus Late Favipiravir Therapy in Hospitalized Patients with COVID-19

Yohei Doi, Masaya Hibino, Ryota Hase et al. · Antimicrobial Agents and Chemotherapy · 2020 · 238 citations · Full text

, , +17

Favipiravir antiviral efficacy against SARS-CoV-2 in a hamster model

Jean‐Sélim Driouich, Maxime Cochin, Guillaume Lingas et al. · Nature Communications · 2021 · 149 citations · Full text

, , +15